Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CLRG
IQ Chaikin US Large Cap ETF
$34.71
+0.3%
$34.21
$30.68
$34.71
$239.50M1.0334,068 shs1,400 shs
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
$26.54
$27.18
$22.82
$30.61
$399.43M0.93248,859 shs147,443 shs
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$86.37
-0.6%
$88.75
$74.05
$91.16
$508.72M0.72123,823 shs91,320 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CLRG
IQ Chaikin US Large Cap ETF
0.00%0.00%0.00%0.00%+7.66%
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
0.00%0.00%0.00%0.00%0.00%
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
-0.63%+1.39%-3.74%+2.44%+8.59%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CLRG
IQ Chaikin US Large Cap ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
N/AN/AN/AN/AN/AN/AN/AN/A
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CLRG
IQ Chaikin US Large Cap ETF
0.00
N/A$37.006.59% Upside
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
0.00
N/AN/AN/A
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
0.00
N/A$95.3610.41% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CLRG
IQ Chaikin US Large Cap ETF
N/AN/AN/AN/AN/AN/A
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
N/AN/AN/AN/AN/AN/A
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CLRG
IQ Chaikin US Large Cap ETF
N/AN/A18.80N/AN/AN/AN/AN/A
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
N/AN/A14.84N/AN/AN/AN/AN/A
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
N/AN/A20.57N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CLRG
IQ Chaikin US Large Cap ETF
$0.531.53%N/AN/AN/A
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
$1.816.82%N/AN/A1 Years
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$1.561.81%N/AN/AN/A

Latest CLRG, PPH, and ISDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/28/2024
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
$0.53284/1/20244/2/20244/5/2024
(Data available from 1/1/2013 forward)

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CLRG
IQ Chaikin US Large Cap ETF
147,0006.90 millionN/ANot Optionable
Invesco RAFI Strategic Developed ex-US ETF stock logo
ISDX
Invesco RAFI Strategic Developed ex-US ETF
147,00015.05 millionN/ANot Optionable
VanEck Pharmaceutical ETF stock logo
PPH
VanEck Pharmaceutical ETF
147,0005.89 millionN/AOptionable

CLRG, PPH, and ISDX Headlines

SourceHeadline
PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns
seekingalpha.com - April 23 at 7:30 AM
Canada’s updated guidance on ESG-related investment fund disclosureCanada’s updated guidance on ESG-related investment fund disclosure
theglobeandmail.com - April 18 at 10:38 AM
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in FocusJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
zacks.com - April 17 at 11:00 AM
VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328
msn.com - April 3 at 8:35 AM
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328
msn.com - April 1 at 2:26 PM
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
zacks.com - March 8 at 7:21 AM
The Top 3 ETFs to Buy in March 2024The Top 3 ETFs to Buy in March 2024
investorplace.com - March 7 at 1:43 PM
11 Granolas Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
markets.businessinsider.com - February 28 at 3:40 PM
Navigate to Success With These 4 Pharma Stocks to BuyNavigate to Success With These 4 Pharma Stocks to Buy
stocknews.com - February 28 at 1:01 PM
The 3 Hottest Healthcare ETFs to Buy in 2024The 3 Hottest Healthcare ETFs to Buy in 2024
investorplace.com - February 26 at 2:12 PM
PPH VanEck Pharmaceutical ETFPPH VanEck Pharmaceutical ETF
seekingalpha.com - February 21 at 8:39 PM
Healthcare dealmakers see increased M&A, valuations in 2024: KPMGHealthcare dealmakers see increased M&A, valuations in 2024: KPMG
msn.com - February 20 at 7:16 AM
Pharma ETF (PPH) Hit a 52-Week HighPharma ETF (PPH) Hit a 52-Week High
zacks.com - February 19 at 9:50 AM
Big Pharma earnings season in spotlight amid positive sentimentBig Pharma earnings season in spotlight amid positive sentiment
msn.com - January 28 at 1:06 PM
5 ETF Zones Scaling New Highs at the Start of 20245 ETF Zones Scaling New Highs at the Start of 2024
finance.yahoo.com - January 8 at 1:13 PM
Pfizer in 2024: What to expect?Pfizer in 2024: What to expect?
msn.com - December 29 at 1:39 PM
Gilead in 2024: What to expect?Gilead in 2024: What to expect?
msn.com - December 28 at 1:41 PM
ETFs to buy and sell as the GLP-1 craze boomsETFs to buy and sell as the GLP-1 craze booms
cnbc.com - December 6 at 9:53 AM
10 Best Performing Healthcare ETFs in 202310 Best Performing Healthcare ETFs in 2023
uk.finance.yahoo.com - November 14 at 4:43 PM
Pharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your PortfolioPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your Portfolio
msn.com - November 6 at 1:27 PM
PPH ETF Stock Price HistoryPPH ETF Stock Price History
investing.com - November 1 at 5:10 PM
PPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling PortfolioPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfolio
msn.com - October 29 at 7:35 AM
3 Resilient Pharma Stocks to Buy This Week3 Resilient Pharma Stocks to Buy This Week
stocknews.com - October 26 at 9:05 PM
Ozempic craze drives big flows into pharmaceutical, Danish fundsOzempic craze drives big flows into pharmaceutical, Danish funds
msn.com - October 25 at 12:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

IQ Chaikin US Large Cap ETF

NASDAQ:CLRG
The IQ Chaikin U.S. Large Cap ETF (CLRG) is an exchange-traded fund that is based on the NASDAQ Chaikin Power US Large Cap index. The fund tracks an equal-weighted index of large-cap US stocks selected based on a multi-factor model. CLRG was launched on Dec 13, 2017 and is managed by IndexIQ.
Invesco RAFI Strategic Developed ex-US ETF logo

Invesco RAFI Strategic Developed ex-US ETF

NASDAQ:ISDX
The Invesco RAFI Strategic Developed ex-US ETF (ISDX) is an exchange-traded fund that is based on the Invesco Strategic Developed ex-US index. The fund tracks an index of large firms in developed markets, ex-US. Stocks are selected by fundamental and quality metrics and weighted by firm size. ISDX was launched on Sep 12, 2018 and is managed by Invesco.
VanEck Pharmaceutical ETF logo

VanEck Pharmaceutical ETF

NASDAQ:PPH
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.